ADI-PEG in Patients With Metastatic Melanoma - Related Studies

ADI-PEG in Patients With Metastatic Melanoma

This study has been completed.

Study NCT00029900. Last updated on January 31, 2006. Information provided by FDA Office of Orphan Products Development

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Melanoma
		Neoplasm Metastasis

2	More general conditions related to this trial
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms, Germ Cell and Embryonal
		Neoplasms, Nerve Tissue
		Neoplastic Processes
		Neuroectodermal Tumors
		Neuroendocrine Tumors
		Nevi and Melanomas
		Pathologic Processes

3	Interventions listed in this trial
		ADI PEG

4	Sponsors listed in this trial
		FDA Office of Orphan Products Development